In contrast to metastatic prostate cancer, data from TCGA regarding primary prostate adenocarcinomas (Supplementary Figure S3B) showed a great disparity in OXER1 levels of expression. The gene discussed is OXER1; the disease is metastatic prostate carcinoma.